"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
Kenneth Newell
Create your FREE profile now!

Join the discussion with physicians and researchers around the globe - sign up for your free Cureus account today.


Dr. Newell came to Emory from the University of Chicago, where he had been serving as director of kidney and pancreas transplantation. Prior to joining the faculty of UChicago, he earned a PhD in immunology and completed an abdominal transplantation fellowship at the institution. He received his medical degree from the University of Michigan and completed his general surgery residency at Loyola Medical Center in Illinois.

At Emory, Dr. Newell established the unrelated paired donor kidney exchange program in 2007 and served as director of the living donor kidney transplant program until stepping down in 2014 so he could spend more time tending to his national responsibilities.

Currently, Dr. Newell is leading the Emory component of a multicenter trial in the Immune Tolerance Network of the National Institute of Allergy and Infectious Diseases (NIAID). The study is evaluating kidney transplant recipients who were able to stop taking immunosuppressive drugs without serious side effects. In the June 2010 edition of theJournal of Clinical Investigation, Dr. Newell and his colleagues described the identification of a pattern of genes in the occasional kidney transplant recipient that switches on in their white blood cells. Since this pattern eventually may be used to help identify other transplant recipients who could reduce or completely taper their immunosuppressive therapy, Dr. Newell is conducting additional studies and compiling a patient registry. He is also involved in optimizing belatacept as an immunosuppressant in renal transplantation.